Sumisaujana Group BhdXKLS:0349 EBIT per Share is RM0.01 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,336 Chemicals companies, Sumisaujana Group Bhd ranks worse than 61% on this metric.
Sumisaujana Group Bhd's EBIT per Share for the
three
months ended in Mar. 2026 was RM0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.01.
During the past 12 months, the average EBIT per Share Growth Rate of Sumisaujana Group Bhd was 22.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -8.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sumisaujana Group Bhd's EBIT per Share or its related term are showing as below:
XKLS:0349'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -8.6 Med: 10 Max: 28.6
Current: -8.6
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Sumisaujana Group Bhd was 28.60% per year. The lowest was -8.60% per year. And the median was 10.00% per year.
XKLS:0349's 3-Year EBIT Growth Rate is ranked worse than 61% of 1336
companies
in the Chemicals industry
Industry Median: -1.15
vs XKLS:0349: -8.60
Sumisaujana Group Bhd (XKLS:0349) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sumisaujana Group Bhd EBIT per Share Related Terms
Sumisaujana Group Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for Sumisaujana Group Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sumisaujana Group Bhd (XKLS:0349) has a EBIT per Share of RM0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sumisaujana Group Bhd and its competitors. According to the industry distribution chart, Sumisaujana Group Bhd ranks #815 out of 1336 companies in the Chemicals industry, placing it in the top 61%.
Is Sumisaujana Group Bhd's EBIT per Share too high?
Sumisaujana Group Bhd's current EBIT per Share is RM0.01. Based on the distribution chart, Sumisaujana Group Bhd ranks #815 out of 1336 companies in the Chemicals industry, which is below the industry midpoint.
How does Sumisaujana Group Bhd's EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Sumisaujana Group Bhd ranks #815 out of 1336 companies for EBIT per Share. This places Sumisaujana Group Bhd in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sumisaujana Group Bhd and its competitors. Sumisaujana Group Bhd's current EBIT per Share is RM0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumisaujana Group Bhd stock overvalued right now?
Sumisaujana Group Bhd (XKLS:0349) has a current EBIT per Share of RM0.01. The current EBIT per Share is RM0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sumisaujana Group Bhd (XKLS:0349), the current EBIT per Share is RM0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sumisaujana Group Bhd is an investment holding company, through its Subsidiary it is principally involved in the manufacturing of O&G specialty chemicals, trading of O&G specialty and industrial chemicals, and provision of related support services. It is principally a manufacturer of O&G specialty chemicals focusing on drilling fluid chemicals, and production and refinery chemicals for the upstream, midstream and downstream segments in the O&G industry. The company operates in two segments: The manufacturing segment and the Trading and related support services segment. The majority of revenue is derived from the manufacturing segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0349 has been successfully added to your 